Browsing ICR Divisions by subject "Ra-223"
Now showing items 1-1 of 1
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer. (2017-09)PURPOSE: Radium Ra 223 dichloride (radium-223, Xofigo®) is the first targeted alpha therapy for patients with castration-resistant prostate cancer and symptomatic bone metastases. Radium-223 provides a new treatment option ...